rEEG Guided Pharmacotherapy of Subjects With Depression Treatment Failure
Public ClinicalTrials.gov record NCT00437827. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Blinded, Controlled, Parallel Group Trial to Demonstrate the Efficacy of rEEG Guided Pharmacotherapy of Subjects With Depression Treatment Failure
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is testing a process (rEEG)for selecting the most appropriate medication(s) to treat a patient's depression versus a control group being treated according to a standardized method, the modified Star\*D Algorithm. Qualified subjects will be randomized to the experimental (rEEG guided) group, or the control group and treated for 12 weeks. Medications utilized in this study are currently marketed. All visits, physical exam, rEEG, labs, rating scales and medications are provided at no cost to the patient.
Study identification
- NCT ID
- NCT00437827
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2006 (Type not available)
- Primary completion
- Oct 2009 (Actual)
- Completion
- Oct 2009 (Actual)
- Last update posted
- Oct 27, 2009
2006 – 2009
United States locations
- U.S. sites
- 13
- U.S. states
- 8
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Behavioral Research Specialists | Glendale | California | 91204 | — |
| University of California - Irvine | Irvine | California | 92868 | — |
| Shanti Research and Clinical Trials | San Bernardino | California | 92324 | — |
| Stanford University | Stanford | California | 94305-5401 | — |
| Elite Clinical Trials | Wildomar | California | 92595 | — |
| Radiant Research | Denver | Colorado | 80212 | — |
| Hawaii Clinical Research Center | Honolulu | Hawaii | 96826 | — |
| Rush University | Chicago | Illinois | 60612 / 60076 | — |
| McClean Hospital/Harvard | Belmont | Massachusetts | 02478-9106 | — |
| Harvard Medical School - Cambridge Hospital | Cambridge | Massachusetts | 02139 | — |
| Alpha Behavioral Care, P.A. | Summit | New Jersey | 07901 | — |
| Cornell University | New York | New York | 10021 | — |
| Univ of TX Health Science Center | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00437827, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 27, 2009 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00437827 live on ClinicalTrials.gov.